In March, Filament Ventures Corp. (now Filament Health) (NEO: FH), acquired Psilo Scientific Ltd.
Psilo Scientific Ltd. is an exclusively natural psychedelic drug discovery and extraction company and is now the flagship asset held by Filament Ventures Corp., which has since completed its going public transaction.
We advised Filament Health with a team led by Jonathan Conlin (M&A) and included Mark Hughes (M&A, Technology).
Jurisdiction
- British Columbia
